Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

2

Revenue 2017

Novartis

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Novartis' 2013 sales performance.

Novartis

Henry Skinner has been appointed as the first CEO of the AMR Action Fund

Henry Skinner has been appointed as the first CEO of the AMR Action Fund Prior to that, he has served as vice president and deputy head and managing director of the Novartis Venture Fund, as well as executive director, head strategic alliances at Novartis Institutes

Novartis partners with Bill & Melinda Gates Foundation on ‘accessible’ sickle cell gene therapy

Novartis partners with Bill & Melinda Gates Foundation on ‘accessible’ sickle cell gene therapy The Gates Foundation will provide funding support for a wholly-dedicated research team within the Novartis Institutes for BioMedical Research (NIBR) for the development of this potential treatment. ... added. As part of the agreement strategy, Novartis

Rare genetic diseases – what’s in store for 2021?

Rare genetic diseases – what’s in store for 2021? Novartis HQ in Basel, Switzerland. Who would have predicted a complete worldwide shutdown in 2020? ... Mike Fraser is General Manager, EMEA at Novartis Gene Therapies. 16th February 2021. .

Sandoz to acquire GSK’s cephalosporin antibiotic brands for up to $500m

Sandoz to acquire GSK’s cephalosporin antibiotic brands for up to $500m Sandoz, the generics division of Novartis, will pay $350m upfront for three established brands. ... Novartis’ generics division Sandoz has signed an agreement with British drugmaker GlaxoSmithKline (GSK) to acquire its cephalosporin antibiotics brands

FDA approves BMS’ blood cancer CAR T therapy after delay

FDA approves BMS’ blood cancer CAR T therapy after delay Breyanzi joins other approved CAR T therapies on the market from Gilead/Kite and Novartis. ... Novartis’ Kymriah (tisagenlecleucel) was approved soon afterwards, also gaining clearance for the treatment of relapsed/refractory diffuse large B-cell

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

Building the hospital of the future
Senior Consultant Leah Carlisle explores the growing trend of virtual hospitals and what it takes to develop a holistic digital ecosystem centered on the ultimate patient experience....
Why people join a clinical trial
To understand why people decide to take part in clinical trials, you first need to understand how people make decisions....
Article:
The disparity of patient experiences with Crohn’s Disease in Europe and Japan...